PHAR
Pharming Group NVNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Momentum Small Cap
$9.44-1.77%
Close Oct 13, 2026
- Market cap
- $662.13M
- 1 month
- -12.8%
- 3 months
- -29.6%
- 1 year
- -33.8%
- 52-week range
- $9.44$21.18
- Dividend
- No dividends on record
- Short interest
- 0.0% of float20.1K shares · settled Sep 30, 2026 · -3.8% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if PHAR is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
4 top institutions tracked
as of 2026-Q2 (filed 2026-09-10)
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
17 filers reported a long position in PHAR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Silverberg Bernstein Capital Management LLC | $577.1K | 41.5K | -7.2% |
| Crossmark Global Holdings, Inc. | $169K | 12.5K | New |
| CITADEL ADVISORS LLC | $162.3K | 12K | +17.5% |
| MORGAN STANLEY | $159.7K | 11.5K | +0.1% |
| SmartHarvest Portfolios, LLC | $144.7K | 10.4K | -3.5% |
| Knoll Capital Management, LLC | $56.8K | 4.1K | +0.8% |
| Silver Grove Financial Group, Inc. | $14.9K | 1.1K | New |
| Nalls Sherbakoff Group, LLC | $12.1K | 870 | Unchanged |
| Global Retirement Partners, LLC | $6.3K | 456 | — |
| Integrated Wealth Concepts LLC | $5.3K | 380 | New |
Get the Full Analysis for PHAR
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.